E. S. Tsurkalenko

Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

C. Waters, A. Hsu, Suneel K. Gupta, 2015, CNS Drugs.